<DOC>
	<DOCNO>NCT00108355</DOCNO>
	<brief_summary>This clinical trial compare combination two drug constrict blood vessel ( Octreotide LAR Midodrine ) albumin large volume paracentesis . Subjects cirrhosis ascites .</brief_summary>
	<brief_title>Vasoconstrictors Alternatives Albumin After Large-Volume Paracentesis ( LVP ) Cirrhosis</brief_title>
	<detailed_description>This prospective , placebo-controlled , randomize , clinical trial compare effect combination vasoconstrictor ( octreotide plus midodrine ) albumin time recurrence ascites patient refractory ascites treat large volume paracentesis . The treatment allocation ratio two treatment arm 1:1 use stratified random permute block design . Subjects patient 18-80 year old cirrhosis ascites stratify accord presence absence renal dysfunction time randomization . Measurements include blood pressure , weight , girth , abdominal ultrasound , forearm blood flow , plasma renin activity , angiotensin , aldosterone , repeat 6 month period .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Ascites</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<mesh_term>Vasoconstrictor Agents</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<criteria>Cirrhosis etiology Age 1880 year Moderate severe ascites No small ascites Severe hepatic hydrothorax Recent GI ( gastrointestinal ) hemorrhage Active bacterial infection Cardiac failure Organic renal disease Hepatocellular carcinoma Severe comorbidity ( advanced neoplasia ) Serum creatinine &gt; 3 mg/dl Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>albumin</keyword>
	<keyword>ascites</keyword>
	<keyword>paracentesis</keyword>
</DOC>